Intrinsic Value of S&P & Nasdaq Contact Us

Humacyte, Inc. HUMA

NASDAQ Global Select

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.50
+511.3%

Humacyte, Inc. (HUMA) current share price is $0.74. The gold spot price is $4,830.80 per troy ounce. Using the formula: HUMA in gold = $0.74 × 31.1035 ÷ $4,830.80 = 0.0047 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of HUMA when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding HUMA shares over the measured period.

HUMA in US Dollars
Gold in US Dollars
HUMA in Gold (grams per share)

Real Wealth Growth Rate

HUMA
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{HUMA}_{\text{gold}}(t) = \frac{P_{\text{HUMA}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{HUMA}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{HUMA}_{\text{gold}}^{(T)}}{\text{HUMA}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{HUMA}_\text{gold}^{(0)}$ = initial gold-price, $\text{HUMA}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

CYTK
CYTK
Cytokinetics, Incorporated
$65.37
-1.48%
MIRM
MIRM
Mirum Pharmaceuticals, Inc.
$96.40
-0.52%
CRNX
CRNX
Crinetics Pharmaceuticals, Inc.
$39.77
+0.05%
GPCR
GPCR
Structure Therapeutics Inc.
$54.25
+1.94%
IMCR
IMCR
Immunocore Holdings plc
$31.64
-0.16%
NRIX
NRIX
Nurix Therapeutics, Inc.
$16.97
+4.11%
VRDN
VRDN
Viridian Therapeutics, Inc.
$14.88
-2.04%
KALV
KALV
KalVista Pharmaceuticals, Inc.
$20.86
+2.81%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message